RC
RCAR.US RenovaCare Inc
- Market cap
- USD 8.74K
- P/E
- -
- P/B
- 5.11x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.
Is RCAR.US undervalued?
Graham numberThe Graham number of RenovaCare Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
RenovaCare Inc fundamental analysis
No fundamental analysis for RenovaCare Inc yet.
RenovaCare Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About RenovaCare Inc
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Sys…
Full company profileRenovaCare Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
RenovaCare Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
| Gross Profit | - | 0.00 | 0.00 | -53.00 | -317.00 | -317.00 | -264.00 | -22.0K | -11.0K | - | - |
| Operating Income | -629K | -2.13M | -1.32M | -1.90M | -2.70M | -2.01M | -3.69M | -9.68M | -5.41M | - | - |
| EBITDA | -629K | -2.13M | -1.32M | -1.90M | -2.70M | -2.01M | -3.36M | -9.67M | -5.40M | - | - |
| Net Income | -1.03M | -2.13M | -1.32M | -2.08M | -3.69M | -2.12M | -3.36M | -9.55M | -4.47M | - | - |
| EPS | -0.02 | -0.03 | -0.02 | -0.03 | -0.05 | -0.03 | -0.04 | -0.11 | -0.05 | - | - |
| Balance Sheet | |||||||||||
| Total Assets | 1.75M | 853K | 561K | 603K | 3.06M | 15.7M | 12.4M | 8.40M | 3.65M | - | - |
| Total Liabilities | 55.4K | 379K | 336K | 364K | 1.40M | 393K | 281K | 1.32M | 1.31M | - | - |
| Shareholders' Equity | 1.70M | 474K | 225K | 239K | 1.66M | 15.3M | 12.2M | 7.08M | 2.35M | - | - |
| Cash & Short-term Investments | 1.51M | 683K | 398K | 418K | 2.91M | 15.4M | 12.2M | 7.41M | 2.85M | - | - |
| Total Debt | - | - | - | 165K | 1.04M | - | - | 79.7K | 30.5K | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -350K | -826K | -1.30M | -1.79M | -1.67M | -2.03M | -3.21M | -4.72M | -4.56M | - | - |
| Capital Expenditure | 163K | 951.00 | 951.00 | 951.00 | 41.3K | 41.3K | 41.3K | 41.3K | 0.00 | 0.00 | - |
| Free Cash Flow | -513K | -826K | -1.30M | -1.79M | -1.67M | -2.03M | -3.21M | -4.76M | -4.56M | - | - |
| Ratios | |||||||||||
| ROE | -60.8% | -449.3% | -586.1% | -868.2% | -221.6% | -13.8% | -27.6% | -134.9% | -190.3% | - | - |
| ROA | -58.9% | -249.8% | -235.1% | -344.4% | -120.5% | -13.5% | -27.0% | -113.7% | -122.3% | - | - |
| Debt to Equity | - | - | - | 0.69x | 0.62x | - | - | 0.01x | 0.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Debt to Equity
- Total debt divided by shareholders' equity.
RenovaCare Inc dividends
RenovaCare Inc has not paid dividends in the last 10 fiscal years.
Last stock split: 6:1 on Sep 15, 2004.
Who owns RenovaCare Inc
Ownership data of RenovaCare Inc is not available yet.
RenovaCare Inc company profile
- Company name
- RenovaCare Inc
- Ticker
- RCAR.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1
- Fiscal year end
- December
- Address
- 9375 East Shea Blvd, Scottsdale, AZ, United States, 85260
- Phone
- 888 398 0202
- Website
- renovacareinc.com
About RenovaCare Inc
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.
RenovaCare Inc management
3- Mr. Harmel S. RayatPresident, CEO, CFO & Interim Secretary · born 1961
- Mr. Justin Frere CPA, M.B.A.Treasurer · born 1973
- Dr. Jo Ellen Schweinle M.D.Chief Medical Officer